S. Nakonechnikov

发表

May Measurement Month 2017 in Russia: hypertension treatment and control—Europe

N. Poulter, A. Konradi, O. Rotar, 2019, European heart journal supplements : journal of the European Society of Cardiology.

Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine

I. Chazova, T. Martynyuk, S. Nakonechnikov, 2017 .

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)

R. Akchurin, I. Chazova, O. Stukalova, 2021, Eurasian heart journal.

Eurasian guidelines for the diagnosis and treatment of pulmonary hypertension associated with congenital heart defects in adults (2021)

I. Chazova, O. Stukalova, T. Martynyuk, 2022, Eurasian heart journal.

AMBRISENTAN: THE POSSIBILITY OF THE TREATMENT FOR PULMONARY ARTERIAL HYPERTENSION WITH THE SELECTIVE BLOCKADE OF THE ENDOTHELIN SYSTEM

I. Chazova, S. Nakonechnikov, T. Martynuk, 2014, Eurasian heart journal.

Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry

T. Martynyuk, Z. Valieva, A. V. Zorin, 2020, BioMed research international.

[Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].

I. Chazova, T. Martynyuk, Z. Valieva, 2019, Terapevticheskii arkhiv.

[Clinical guidelines for the diagnosis and treatment of pulmonary hypertension].

I. Chazova, S. Avdeev, I. Chazova, 2014, Terapevticheskii arkhiv.

INNOVATION IN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION: STIMULATOR OF SOLUBLE GYANYLATE CYCLASE - RIOCIGUAT

T. Martynyuk, I. Chazova, S. Nakonechnikov, 2015, Eurasian heart journal.

APPLICATION OF PHOSPHODIESTERASE TYPE 5 INHIBITORS SILDENAFIL IN PATIENTS WITH PULMONARY HYPERTENSION

T. Martynyuk, I. Chazova, S. Nakonechnikov, 2015, Eurasian heart journal.

MANAGEMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE PANDEMIC OF A NEW CORONAVIRUS INFECTION

I. Chazova, T. Martynyuk, A. V. Zorin, 2020 .

NEW OPPORTUNITIES PATHOGENETIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION

S. Nakonechnikov, I. Chazova, T. Martynuk, 2013, Eurasian heart journal.

[Pulmonary hypertension in Russia: the first results of the national register].

I. Chazova, Z. Valieva, S. Nakonechnikov, 2014, Terapevticheskii arkhiv.

FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER

T. Martynyuk, Z. Valieva, I. Chazova, 2014, Eurasian heart journal.

Vasoreactivity testing in pulmonary hypertension associated with congenital heart disease

T. Martynyuk, S. Gorbachevsky, A. A. Shmalts, 2022, Eurasian heart journal.

Pulmonary hypertension: current issues of diagnosis and treatment

I. Chazova, S. Nakonechnikov, T. Martyniuk, 2011, Eurasian heart journal.

MACITENTAN: THE EVOLUTION OF THE CLASS ENDOTHELIN RECEPTOR ANTAGONISTS TO IMPROVE EFFICACY AND SAFETY OF PAH TREATMENT

I. Chazova, S. Nakonechnikov, T. Martynuk, 2013, Eurasian heart journal.

[The effect of long-term Fraxiparin treatment on hemostasis in patients with primary pulmonary hypertension].

I. Chazova, E. Titaeva, A. B. Dobrovol'skii, 1997, Terapevticheskii arkhiv.

DYAGNOSIS AND TREATMENT OF CARDIAC PULMONARY OEDEMA

I. Zhirov, S. Tereschenko, S. Nakonechnikov, 2012, Eurasian heart journal.

[Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].

I. Chazova, T. Martynyuk, Z. Valieva, 2021, Terapevticheskii arkhiv.

Calculation of hemodynamics by the Fick method in pulmonary hypertension associated with congenital heart defects

T. Martynyuk, A. A. Shmalts, S. Nakonechnikov, 2022, Eurasian heart journal.

The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.

I. Chazova, S. Nedogoda, T. Martynyuk, 2018, Terapevticheskii arkhiv.

[Carriage of A Allele of Polymorphic Marker G(-238)A of TNF-alfa Gene Is Associated With Unfavorable Prognosis in Patients With Chronic Systolic Heart Failure].

V. Nosikov, D. Zateyshchikov, V. Masenko, 2015, Kardiologiia.

ACCORDING TO THE RESULTS OF THE EUROPEAN CONGRESS OF CARDIOLOGY 2015: NEW VERSION OF GUIDELINES FOR DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION

T. Martynyuk, I. Chazova, S. Nakonechnikov, 2015, Eurasian heart journal.

OPTIMIZATION OF SPECIFIC THERAPY FOR PULMONARY ARTERIAL HYPERTENSION: THE POSSIBILITIES OF USING ENDOTHELIN RECEPTOR ANTAGONISTS

T. Martynyuk, I. Chazova, S. Nakonechnikov, 2017, Eurasian heart journal.